Vystar Corp (VYST)

[VenOmousInvestor]

The testing in EPA-certified laboratories shows Rx3000 has been proven effective against harmful pathogens including multiple coronaviruses, H1N1, MRSA, pneumonia, strep, TB, measles, influenza, and the common cold and also neutralizes odors, indoor pollutants, and VOCs (volatile organic compounds). And each portable RxAir unit provides four to eight complete air changes per hour (ACH) for a 1500 to 3000 sq. ft. room to minimize risk of infection from airborne diseases for all in the room. RxAir is going to start taking deposits on Rx3000 pre-orders beginning October 18, 2020.